Breaking News, Promotions & Moves

BioClinica Names CEO

Industry veteran Hubbard to succeed Weinstein

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

John Hubbard, Ph.D., FCP, has been appointed chief executive officer and a member of the board of directors at BioClinica, Inc., effective January 5, 2015. Dr. Hubbard joins the company from Pfizer, where he has served as senior vice president and worldwide head of development operations. Dr. Hubbard succeeds Mark Weinstein.   Dr. Hubbard has 30 years of pharmaceutical experience and spearheaded R&D initiatives for some of the industry’s premier organizations. At Pfizer, he was respons...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters